The national importance of falls and bone health is reflected in the:
- National Service Framework for Older People, Chapter 6 “Falls”, Department of Health, London, HMSO (2001) (NSF for Older People)
- National Institute for Health and Clinical Excellence, Clinical Guideline (CG) 21, Falls: the assessment and prevention of falls in older people. November 2004
- National Institute for Health and Clinical Excellence, Technology Appraisal (TA) 87, Bisphosphonates (alendronate, etidonate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in post menopausal women. January 2005